共 39 条
[2]
Aynacioglu AS, 1999, BRIT J CLIN PHARMACO, V48, P409
[3]
BROCKMOLLER J, 2001, PHARMACOL TOXICOL, V89, P107
[4]
Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: Comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype
[J].
PHARMACOGENETICS,
1995, 5 (06)
:358-363
[6]
Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population
[J].
PHARMACOGENETICS,
1998, 8 (01)
:15-26
[7]
Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus
[J].
PHARMACOGENETICS,
2000, 10 (01)
:85-89
[8]
KAMINSKY LS, 1993, MOL PHARMACOL, V43, P234